On ECHEMI
Home > Drugs > Shanghaizhaohui Pharmaceutical Co., Ltd.
Shanghaizhaohui Pharmaceutical Co., Ltd.
  • Founded in:

    1988-03-23
  • Country:

    China China
  • Address:

    No. 2151, Fuyuan Road, Baoshan District, Shanghai
  • Tax NO.:

    913101131332324468
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Tetracaine Hydrochloride
Name Description Content CAS NO. Registered Holders
Tetracaine hydrochloride

136-47-0 16
Lidocaine Hydrochloride Injection
The main ingredient of this product is lidocaine hydrochloride. Its chemical name is N-(dichloroxylyl)-2-(diethylamino)acetamide hydrochloride monohydrate.
Name Description Content CAS NO. Registered Holders
Lidocaine hydrochloride

This product is an amide local anesthetic. After blood absorption or intravenous administration, it has obvious biphasic effects of excitation and inhibition on the central nervous system, and there may be no precursor excitation. When the blood concentration is low, analgesia and drowsiness occur, and the pain threshold increases; with increasing doses, the effect or toxicity increases, and there is an anticonvulsant effect at sub-toxic blood concentrations; convulsions may occur when the blood concentration exceeds 5μg·ml-1. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and have an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction, and myocardial contraction; further increases in blood concentrations can cause a slowing of the heart conduction velocity, atrioventricular conduction block, inhibition of myocardial contractility, and a decrease in cardiac output.

More

This product is an amide local anesthetic. After blood absorption or intravenous administration, it has obvious biphasic effects of excitation and inhibition on the central nervous system, and there may be no precursor excitation. When the blood concentration is low, analgesia and drowsiness occur, and the pain threshold increases; with increasing doses, the effect or toxicity increases, and there is an anticonvulsant effect at sub-toxic blood concentrations; convulsions may occur when the blood concentration exceeds 5μg·ml-1. At low doses, it can promote the outflow of K in myocardial cells, reduce the autonomy of the myocardium, and have an anti-ventricular arrhythmia effect; at therapeutic doses, it has no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction, and myocardial contraction; further increases in blood concentrations can cause a slowing of the heart conduction velocity, atrioventricular conduction block, inhibition of myocardial contractility, and a decrease in cardiac output.

6108-05-0 45
Compound Rutin Tablets
This product is a compound preparation, its components are: rutin and vitamin C
Name Description Content CAS NO. Registered Holders
Rutin

It is a glycoside of dehydrogenated flavonoids, which often coexists with vitamin C in food. It may participate in the action of oxidoreductase in the body, affect the activity of the thyroid gland, protect adrenaline from oxidation, enhance the effect of vitamin C and promote its accumulation in the body, maintain vascular elasticity, enhance capillary resistance, and reduce its fragility and permeability.

More

It is a glycoside of dehydrogenated flavonoids, which often coexists with vitamin C in food. It may participate in the action of oxidoreductase in the body, affect the activity of the thyroid gland, protect adrenaline from oxidation, enhance the effect of vitamin C and promote its accumulation in the body, maintain vascular elasticity, enhance capillary resistance, and reduce its fragility and permeability.

153-18-4 21
Ascorbic Acid

Maintain vascular elasticity, enhance capillary resistance, reduce its fragility and permeability, promote cell proliferation and prevent blood cell aggregation.

More

Maintain vascular elasticity, enhance capillary resistance, reduce its fragility and permeability, promote cell proliferation and prevent blood cell aggregation.

50-81-7 28
Perphenazine tablets
The main ingredient of this product is perphenazine, and its chemical name is: 4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol.
Name Description Content CAS NO. Registered Holders
Prochlorperazine

The antipsychotic effect is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and midbrain-cortex pathways related to emotional thinking, while blocking the α-adrenaline receptors in the reticular formation ascending activation system is related to the sedative and tranquilizing effect. This product has a strong antiemetic effect and a weak sedative effect.

More

The antipsychotic effect is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and midbrain-cortex pathways related to emotional thinking, while blocking the α-adrenaline receptors in the reticular formation ascending activation system is related to the sedative and tranquilizing effect. This product has a strong antiemetic effect and a weak sedative effect.

58-38-8 9
Perphenazine tablets
The main ingredient of this product is perphenazine, and its chemical name is: 4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol.
Name Description Content CAS NO. Registered Holders
Prochlorperazine

The antipsychotic effect is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and mesocortical pathways related to emotional thinking, while blocking the alpha-adrenaline receptors in the reticular formation ascending activation system is related to the sedative and tranquilizing effect. This product has a strong antiemetic effect and a weak sedative effect.

More

The antipsychotic effect is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and mesocortical pathways related to emotional thinking, while blocking the alpha-adrenaline receptors in the reticular formation ascending activation system is related to the sedative and tranquilizing effect. This product has a strong antiemetic effect and a weak sedative effect.

58-38-8 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.